The biotechnology company will look to make impact investments through the Diva non-profit incubator in partnership with corporates.
Denmark-based biotechnology developer Novozymes has formed a not-for-profit incubator called Diva that will invest alongside large corporations, the company told The Guardian on Friday.
In an article co-authored by Novozymes’ head of sustainability innovation, Stefan Maard, and Diva co-founder Morten Møller Holst, the company revealed details of the incubator, which has been formed with World Business Council for Sustainable Development and pro bono assistance from legal firm Pillsbury Law.
Diva will co-invest in impact ventures with corporates, while also utilising…